Michael Nader to Methamphetamine
This is a "connection" page, showing publications Michael Nader has written about Methamphetamine.
Connection Strength
1.594
-
John WS, Newman AH, Nader MA. Differential effects of the dopamine D3 receptor antagonist PG01037 on cocaine and methamphetamine self-administration in rhesus monkeys. Neuropharmacology. 2015 May; 92:34-43.
Score: 0.500
-
John WS, Banala AK, Newman AH, Nader MA. Effects of buspirone and the dopamine D3 receptor compound PG619 on cocaine and methamphetamine self-administration in rhesus monkeys using a food-drug choice paradigm. Psychopharmacology (Berl). 2015 Apr; 232(7):1279-89.
Score: 0.493
-
Lile JA, Charnigo RJ, Nader MA. The relative reinforcing strength of methamphetamine and D-amphetamine in monkeys self-administering cocaine. Behav Pharmacol. 2013 Sep; 24(5-6):482-5.
Score: 0.455
-
Martelle SE, Nader SH, Czoty PW, John WS, Duke AN, Garg PK, Garg S, Newman AH, Nader MA. Further characterization of quinpirole-elicited yawning as a model of dopamine D3 receptor activation in male and female monkeys. J Pharmacol Exp Ther. 2014 Aug; 350(2):205-11.
Score: 0.120
-
Newman AH, Blaylock BL, Nader MA, Bergman J, Sibley DR, Skolnick P. Medication discovery for addiction: translating the dopamine D3 receptor hypothesis. Biochem Pharmacol. 2012 Oct 01; 84(7):882-90.
Score: 0.026